19:14 , Dec 7, 2018 |  BC Week In Review  |  Financial News

Angina gene therapy company XyloCor raises $17M series A round

Gene therapy company XyloCor Therapeutics Inc. (Philadelphia, Pa.) raised $17 million Dec. 6 in a series A round led by Sofinnova Ventures and Life Science Partners. XyloCor’s lead candidate is XC001, a gene therapy that...
21:39 , Dec 6, 2018 |  BC Extra  |  Financial News

Angina gene therapy company XyloCor raises $17M series A round

Gene therapy company XyloCor Therapeutics Inc. (Philadelphia, Pa.) raised $17 million in a series A round led by Sofinnova Ventures and Life Science Partners. XyloCor’s lead candidate is XC001, a gene therapy that stimulates the...
23:03 , Jul 2, 2018 |  BC Extra  |  Company News

Korean company ABL out-licenses antibody programs to U.S.

ABL Bio Inc. (Seongnam, South Korea) granted Trigr Therapeutics Inc. (Irvine, Calif.) global rights to five of its antibody programs, excluding South Korea. ABL will receive $4.3 million up front and be eligible for $550...